MORGAN STANLEY - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 30 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$011
+1000.0%
0.00%
Q2 2022$0
-100.0%
1
-100.0%
0.00%
Q1 2022$2,0002,607
+260600.0%
0.00%
Q4 2021$01
-99.3%
0.00%
Q1 2021$0
-100.0%
142
-94.2%
0.00%
Q4 2020$7,000
-50.0%
2,445
-16.8%
0.00%
Q3 2020$14,000
-30.0%
2,940
-40.5%
0.00%
Q2 2020$20,0004,9430.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders